Steven Gill

Steven Gill

Company: Neurochase

Job title: Founder & Chief Medical Officer


Improving Biodistribution Studies for Neurological Gene Therapies 1:05 pm

Understanding biodistribution in gene therapies for the CNS is holding back many therapies from regulatory approval and commercialisation so presents itself as an area in dire need for better understanding. In this workshop session, join experts in bioanalytics and biodistribution to uncover recent bioanalytical advancements in animal models to build sufficient biodistribution data to apply…Read more

day: Pre-Conference Workshop Day

An Overview of the Neurochase Delivery Technology: Targeted Delivery of CNS Therapeutics 11:00 am

An opportunity for those keen to learn more about a scalable, targeted delivery approach for CNS gene therapy deliveryRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.